Abstract
Patients with advanced malignancies have high-unmet medical needs, which bring requests for early availability of new innovative treatments. Calls for expedited trial formats and rapid regulatory a...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
